Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Butyric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL10520334 | 1.00 | FFAR3 (0.93) | — | |
| Butyric Acid SCHEMBL28476290 | 1.00 | FFAR3 (0.93) | — | |
| Butyric Acid SCHEMBL27318260 | 1.00 | FFAR3 (0.93) | — | |
| Butyric Acid SCHEMBL2234517 | 1.00 | — | — | |
| Butyric Acid SCHEMBL1650329 | 1.00 | — | — | |
| Butyric Acid SCHEMBL2230669 | 1.00 | FFAR3 (0.93) | — | |
| Butyric Acid SCHEMBL6747967 | 0.97 | — | — | |
| Butyric Acid SCHEMBL6234018 | 0.97 | — | — | |
| Butyric Acid SCHEMBL4888893 | 0.97 | — | — | |
| Butyric Acid SCHEMBL6837780 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117534562-A | Preparation method of perfluoro-acetyl fluoride and perfluoro-butyryl fluoride | 浙江利化新材料科技有限公司 | 2024-02-09 | — | — | CN | claimed |
| WO-2020017816-A1 | BIO-IMPLANT COMPRISING SURFACE-MODIFIED ALKALINE CERAMIC PARTICLES AND BIODEGRADABLE POLYMER AND PREPARATION METHOD THEREFOR | 차의과학대학교 산학협력단 | 2020-01-23 | — | — | WO | claimed |
| CN-109715636-A | The method for optical resolution of NAHLSGEN | 国立大学法人京都大学 | 2019-05-03 | — | — | CN | claimed |
| CN-107922379-A | Substituted guanidine derivatives | 宇部兴产株式会社 | 2018-04-17 | — | — | CN | claimed |
| CN-106573923-A | Phenylaminopyrimidine-derived compounds, method for producing the same, use of the compounds for the treatment of cancer, and treatment methods | 奥斯瓦道·克鲁兹基金会 | 2017-04-19 | — | — | CN | claimed |
| CN-102656180-A | Lupeol-type triterpene derivatives as antivirals | HETERO RESEARCH FOUNDATION | 2012-09-05 | — | — | CN | claimed |
| EP-4472963-A1 | DGK TARGETING COMPOUNDS AND USES THEREOF | Arvinas Operations, Inc. (US) | 2024-12-11 | — | — | EP | disclosed |
| CN-118946556-A | DGK targeting compounds and uses thereof | 阿维纳斯运营公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118543309-A | Method for preparing heptafluorobutyryl fluoride by electrochemical method | 上海锐恩百氟科技开发有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-117534562-A | Preparation method of perfluoro-acetyl fluoride and perfluoro-butyryl fluoride | 浙江利化新材料科技有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-117529242-A | Granules containing active substances, method for the production thereof and use thereof in human foods or animal feeds | IDCAPS公司 | 2024-02-06 | — | — | CN | disclosed |
| WO-2022191580-A1 | BIODEGRADABLE POLYMER SUPPORT CONTAINING BIOACTIVE MATERIAL AND MANUFACTURING METHOD THEREFOR | 차의과학대학교 산학협력단 | 2022-09-15 | — | — | WO | disclosed |
| CN-109806437-B | Preparation method of multifunctional composite hemostatic material | 河北考力森生物科技有限公司 | 2022-03-08 | — | — | CN | disclosed |
| CN-1503795-A | Water-soluble triazole antifungal agents | ������������ʽ���� | 2004-06-09 | — | — | CN | disclosed |
| CN-1040656-C | Surfactant-containing dye transfer inhibiting compositions | PROCTER & GAMBLE (US) | 1998-11-11 | — | — | CN | disclosed |
| CN-1196678-A | Di-and trivalent small molecule selecting protein inhibitors | TEXAS BIOTECHANOLOGY CORP (US) | 1998-10-21 | — | — | CN | disclosed |
| CN-1084211-A | The dye transfer inhibiting composition that contains tensio-active agent | PROCTER & GAMBLE (NL) | 1994-03-23 | — | — | CN | disclosed |
| CN-1065455-A | Piperidine derivative | LILLY CO ELI (US) | 1992-10-21 | — | — | CN | disclosed |
| CN-1030761-A | Phosphorated 3-hydroxyl-3-first glutaryl CoA-reductase inhibitors, new intermediate and method | SQUIBB & SONS INC (US) | 1989-02-01 | — | — | CN | disclosed |
| CN-88100569-A | Be used for ethene high temperature (being total to) polymeric catalyst system | — | 1988-10-05 | — | — | CN | disclosed |